Avalo Therapeutics (AVTX) Gross Profit (2017 - 2024)
Avalo Therapeutics (AVTX) posted Gross Profit of -$465000.0 for Q3 2024, down 35.57% on a QoQ basis from -$343000.0 in Q2 2024, and down 4127.27% year-over-year from $11546.3 in Q4 2023.
Avalo Therapeutics (AVTX) Gross Profit (2017 - 2024) Analysis & Trends
Avalo Therapeutics' Gross Profit history runs 8 years deep, the most recent figure standing at -$465000.0 for Q3 2024.
- Quarterly Gross Profit fell 4127.27% year-over-year to -$465000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$96000.0 (down 177.42% YoY) and the FY2023 annual result came in at $640000.0, down 95.62% from the prior year.
- Gross Profit was -$465000.0 for Q3 2024 at Avalo Therapeutics, down from -$343000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $14.4 million in Q3 2022 and bottomed at -$534000.0 in Q2 2022.
- A 5-year average of $1.3 million and a median of $396000.0 in 2021 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit surged 3162.67% — and 2024, when it tumbled 4127.27%.
- Avalo Therapeutics' Gross Profit stood at $1.4 million in 2020, then sank by 114.46% to -$205000.0 in 2021, then surged by 234.63% to $276000.0 in 2022, then soared by 186.96% to $792000.0 in 2023, then sank by 158.71% to -$465000.0 in 2024.
- Business Quant data shows AVTX's Gross Profit at -$465000.0 in Q3 2024, -$343000.0 in Q2 2024, and -$80000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -465,000.00 |
| Sep 30, 2024 | -465,000.00 |
| Jun 30, 2024 | -343,000.00 |
| Jun 30, 2024 | -343,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Mar 31, 2023 | -76,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 14.42 Mn |
| Sep 30, 2022 | 14.42 Mn |
| Jun 30, 2022 | -534,000.00 |
| Jun 30, 2022 | -534,000.00 |